Works matching IS 22351795 AND DT 2024 AND VI 13 AND IP 3

Results: 9

A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial).

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 322, doi. 10.1159/000535514

By:

Ichida, Akihiko;
Arita, Junichi;
Hatano, Etsuro;
Eguchi, Susumu;
Saiura, Akio;
Nagano, Hiroaki;
Shindoh, Junichi;
Hashimoto, Masaji;
Takemura, Nobuyuki;
Taura, Kojiro;
Sakamoto, Yoshihiro;
Takahashi, Yu;
Seyama, Yasuji;
Sasaki, Yasuharu;
Uemura, Kohei;
Kokudo, Norihiro;
Hasegawa, Kiyoshi

Publication type:

Article

Front & Back Matter.

Published in:: Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 1, doi. 10.1159/000539902
Publication type:: Article

Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 227, doi. 10.1159/000538558

By:

Kudo, Masatoshi

Publication type:

Article

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 306, doi. 10.1159/000534513

By:

Sim, Yu Ki;
Chong, Ming Chuen;
Gandhi, Mihir;
Pokharkar, Yogesh Mahadev;
Zhu, Yanan;
Shi, Luming;
Lequn, Li;
Chen, Chien-Hung;
Kudo, Masatoshi;
Lee, Joon Hyeok;
Strasser, Simone I.;
Chanwat, Rawisak;
Chow, Pierce K.H.

Publication type:

Article

Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 246, doi. 10.1159/000534303

By:

Hwang, Sang Youn;
Lee, Sangjune L.;
Liu, Hongqun;
Lee, Samuel S.

Publication type:

Article

Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 235, doi. 10.1159/000533991

By:

Pasta, Andrea;
Calabrese, Francesco;
Jaffe, Ariel;
Labanca, Sara;
Marenco, Simona;
Pieri, Giulia;
Plaz Torres, Maria Corina;
Strazzabosco, Mario;
Giannini, Edoardo G.

Publication type:

Article

Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 285, doi. 10.1159/000533818

By:

Aoki, Tomoko;
Nishida, Naoshi;
Kurebayashi, Yutaka;
Sakai, Kazuko;
Morita, Masahiro;
Chishina, Hirokazu;
Takita, Masahiro;
Hagiwara, Satoru;
Ida, Hiroshi;
Ueshima, Kazuomi;
Minami, Yasunori;
Tsurusaki, Masakatsu;
Nakai, Takuya;
Sakamoto, Michiie;
Nishio, Kazuto;
Kudo, Masatoshi

Publication type:

Article

PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 256, doi. 10.1159/000533650

By:

Abou-Alfa, Ghassan K.;
Galle, Peter R.;
Chao, Yee;
Erinjeri, Joseph;
Heo, Jeong;
Borad, Mitesh J.;
Luca, Angelo;
Burke, James;
Pelusio, Adina;
Agathon, Delphine;
Lusky, Monika;
Breitbach, Caroline;
Qin, Shukui;
Gane, Edward

Publication type:

Article

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 273, doi. 10.1159/000533425

By:

Chiang, Chi Leung;
Lee, Francis Ann Shing;
Chan, Kenneth Sik Kwan;
Lee, Venus Wan Yan;
Chiu, Keith Wan Hang;
Ho, Ryan Lok Man;
Fong, John Ka Shun;
Wong, Natalie Sean Man;
Yip, Winnie Wing Ling;
Yeung, Cynthia Sin Yu;
Lau, Vince Wing Hang;
Man, Kwan;
Kong, Feng-Ming Spring;
Chan, Albert Chi Yan

Publication type:

Article